Dr. Ashish Jha Outlines Priorities for the New Congress on Healthcare Costs and Science
17 Nov 2026
What should the new Congress prioritize when it comes to American healthcare?
For Dr. Ashish K. Jha, two issues stand out: reducing the cost of care for American families and protecting the scientific institutions responsible for advancing medicine.
In a new Boston Globe opinion essay, also shared through his A Moment in Health newsletter, Jha argues that the next phase of healthcare policy should focus not only on who pays for care, but also on why care costs so much and how the United States can preserve its capacity for scientific discovery.
Jha distills that argument into two responsibilities for the new Congress: make healthcare more affordable for families struggling with rising costs and protect the scientific institutions that will deliver tomorrow’s treatments and sustain American innovation.
As he writes:
The new Congress has two responsibilities: make health care more affordable for families struggling with rising costs and protect the scientific institutions that will deliver tomorrow’s treatments and keep America at the forefront of innovation. Americans should be able to afford the care available today and count on American science to improve it. Congress should get to work.
As a physician, scientist, former White House COVID-19 Response Coordinator, and longtime health-policy researcher, Jha approaches both questions through the lens of affordability, evidence, and the long-term strength of the healthcare system.
Dr. Ashish Jha on Healthcare Affordability and Protecting Scientific Research
On healthcare costs, Jha argues that maintaining insurance coverage is important but does not by itself address the underlying prices and inefficiencies driving American healthcare spending. He points to areas including payment reform, price transparency, competition, and administrative burdens such as prior authorization as opportunities for Congress to address costs more directly.
The second half of his argument focuses on American science and medical innovation. Jha calls for sustained investment in biomedical research and stronger protections for scientific independence, including peer-review processes, researchers’ ability to publish their findings, and greater transparency around changes to federal research priorities.
The two issues, he argues, are connected. Americans need access to the treatments available today while the country continues investing in the discoveries that could improve care tomorrow.
These questions closely reflect the issues Jha addresses in his work as a keynote speaker. His current presentations examine healthcare costs and reform, trust in science and medicine, artificial intelligence in healthcare, biosecurity, and high-stakes leadership. His work focuses on helping audiences understand complex health and policy challenges while identifying practical paths forward.
Today, Jha is Co-Founder and CEO of BioRadar and a Senior Fellow at Harvard Kennedy School’s Belfer Center for Science and International Affairs. Throughout his career, he has worked across medicine, government, academia, and public health, translating research and evidence into decisions affecting healthcare systems and communities.